Smartwatch could alert doctors to brain cancer complications before they worsen
NCT ID NCT07704034
First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time
Summary
This study tests whether a consumer smartwatch (Apple Watch or Samsung Galaxy Watch) can continuously monitor people with leptomeningeal metastasis, a condition where cancer spreads to the fluid and membranes around the brain and spinal cord. The watch collects data on movement and symptoms, and if it detects early signs of neurological decline, it automatically alerts the participant's doctor. The goal is to see if this early warning system can reduce hospitalizations by enabling faster medical intervention.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Apple Watch Series 6+ or Samsung Galaxy Watch 4+ with a cross-platform app for passive monitoring and active alerts
- What this could lead to
- If successful, this approach could provide a way to catch neurological decline early in people with leptomeningeal metastasis, potentially reducing hospital stays and improving quality of life.
- What could go wrong
- This is a small, early feasibility study, so the smartwatch alerts may not reliably predict decline or reduce hospitalizations. The technology might also be burdensome for participants to use consistently.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEPTOMENINGEAL METASTASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cleveland Clinic, Case Comprehensive Cancer Center
Cleveland, Ohio, 44106, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Spinal injection of dual immunotherapy plus chemotherapy targets cancer spread to brain lining
- Spinal fluid injection of Dual-Target antibody and chemotherapy shows promise for deadly cancer complication
- Triple therapy targets tough brain metastases in lung cancer
- New hope for lung cancer patients with brain-spread disease
- New hope for lung cancer patients with brain spread: targeted pill under study
- New drug combo targets brain tumors with genetic flaw